Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Category

Sub-category

Conference

The immuno side of melanoma

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA

The immuno side of melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )

Use of mesenchymal stromal cells against graft-versus-host disease

Prof Willem Fibbe – Lieden University Medical Center, Holland

Use of mesenchymal stromal cells against graft-versus-host disease ( Prof Willem Fibbe – Lieden University Medical Center, Holland )

Next generation sequencing and the monoclonal structure of multiple myeloma

Dr Niccolo Bolli – University of Cambridge, UK

Next generation sequencing and the monoclonal structure of multiple myeloma ( Dr Niccolo Bolli – University of Cambridge, UK )

Assessing iron overload and toxicity

Prof John Porter - University College London, UK

Assessing iron overload and toxicity ( Prof John Porter - University College London, UK )

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )

Drug development in small cell and non-small cell lung cancer

Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA

Drug development in small cell and non-small cell lung cancer ( Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma

Dr Sagar Lonial – Emory University, Atlanta, USA

Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma ( Dr Sagar Lonial – Emory University, Atlanta, USA )

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK

Effects of panitumumab against oesophageal-gastro cancer and carcinomas ( Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK )

Regorafenib effective for GISTs that progress due to resistance to approved...

Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA

Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA )

ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma

Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Mathias...

ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma ( Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Mathias Rummel - University Hospital Giessen, Germany )

ASCO 2012: Advances in metastatic castration-resistant prostate cancer; first...

Dr Chris Parker - Royal Marsden Cancer Centre, London, UK; Prof Stéphan Oudard...

ASCO 2012: Advances in metastatic castration-resistant prostate cancer; first-line cabazitaxel ( Dr Chris Parker - Royal Marsden Cancer Centre, London, UK; Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, France )

Increased risk of breast cancer among young women treated with radiation as a...

Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA

Increased risk of breast cancer among young women treated with radiation as a child ( Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA )

More from ecancer